STOCK TITAN

Synergy CHC Corp. Announces Third Quarter 2025 Earnings and Conference Call Information

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Synergy CHC Corp (NASDAQ: SNYR) will release third quarter 2025 financial results for the period ended September 30, 2025 on Thursday, November 13, 2025 before market open.

The company will host a conference call on the same day at 9:00 a.m. ET / 6:00 a.m. PT with CEO Jack Ross and CFO Jaime Fickett. A live webcast and a limited-time replay will be available on Synergy's Investor Relations website. Phone participants must register to receive dial-in details and are encouraged to join 15 minutes early to avoid delays.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+3.08%
1 alert
+3.08% News Effect
+$819K Valuation Impact
$27M Market Cap
0.1x Rel. Volume

On the day this news was published, SNYR gained 3.08%, reflecting a moderate positive market reaction. This price movement added approximately $819K to the company's valuation, bringing the market cap to $27M at that time.

Data tracked by StockTitan Argus on the day of publication.

WESTBROOK, Maine, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that it plans to release financial results for the third quarter ended September 30, 2025, on Thursday, November 13, 2025, before the open of market trading.

In conjunction with reporting third quarter 2025 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company’s Chief Executive Officer, Jack Ross, and the Company’s Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Synergy’s website. To access the call by phone, please register here and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call 15 minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time on the Company’s website.

About Synergy CHC Corp.

Synergy CHC Corp. develops and markets consumer health and wellness products, led by its flagship brands FOCUSfactor® and Flat Tummy®. FOCUSfactor®, a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution in the U.S., Canada, and the U.K. through major retailers including Costco, Walmart, Amazon, BJ's, and Walgreens, among others. The brand continues to accelerate growth, penetrating new markets both domestically and internationally, with recent retail wins across mass, grocery, pharmacy, convenience, and wholesale channels poised to drive meaningful gains in late 2025. Flat Tummy® complements Synergy's portfolio as a lifestyle brand focused on women's wellness and weight management.

Investor Relations

Gateway Group
Cody Slach, Greg Robles
949.574.3860
SNYR@gateway-grp.com


FAQ

When will Synergy CHC Corp (SNYR) report Q3 2025 results?

Synergy will report Q3 2025 results on Thursday, November 13, 2025 before market open.

What time is the Synergy (SNYR) Q3 2025 conference call and who will speak?

The call is at 9:00 a.m. ET / 6:00 a.m. PT with CEO Jack Ross and CFO Jaime Fickett.

How can investors join the Synergy (SNYR) Q3 2025 earnings call by phone?

Phone participants must register to receive dial-in details; registration provides the call access information.

Where can I watch the Synergy CHC (SNYR) Q3 2025 earnings webcast?

A live webcast and a limited-time replay will be available on Synergy's Investor Relations website.

Will there be a replay of the Synergy (SNYR) Q3 2025 earnings webcast?

Yes, a replay will be posted on the company website for a limited time after the call.

Is there guidance on when to join the Synergy (SNYR) conference call to avoid delays?

Investors are encouraged to dial in 15 minutes before the scheduled start time to avoid delays.
Synergy Chc Corp

NASDAQ:SNYR

SNYR Rankings

SNYR Latest News

SNYR Latest SEC Filings

SNYR Stock Data

19.35M
4.90M
56.75%
3.82%
1.06%
Medical Distribution
Medicinal Chemicals & Botanical Products
Link
United States
WESTBROOK